Latest Articles
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com
Published: Feb. 11, 2026, 12:24 p.m.
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH - Dove Medical Press
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH Dove Medical Press
Published: Feb. 11, 2026, 9:02 a.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape
Published: Feb. 11, 2026, 8:49 a.m.
Research project of the year: What the judges want to see - FemTech World
Research project of the year: What the judges want to see FemTech World
Published: Feb. 11, 2026, 8:36 a.m.
The School Nurse Training Program Redefining Endometriosis Care for Students - Endometriosis Foundation of America
The School Nurse Training Program Redefining Endometriosis Care for Students Endometriosis Foundation of America
Published: Feb. 10, 2026, 10:33 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - Bioengineer.org
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on Bioengineer.org
Published: Feb. 10, 2026, 6:37 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - BIOENGINEER.ORG
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on BIOENGINEER.ORG
Published: Feb. 10, 2026, 6:37 p.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India
Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade
Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE
Published: Feb. 10, 2026, 10:07 a.m.
Link copied to clipboard!